PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers.
DNA repair
PARP inhibitors
homologous recombination repair
prostate cancers
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
21 Mar 2022
21 Mar 2022
Historique:
received:
04
02
2022
revised:
07
03
2022
accepted:
14
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Despite recent improvements in survival, metastatic castration-resistant prostate cancers (mCRPCs) remain lethal. Alterations in genes involved in the homologous recombination repair (HRR) pathway are associated with poor prognosis. Poly-ADP-ribose polymerase (PARP) inhibitors (PARPis) have demonstrated anti-tumoral effects by synthetic lethality in patients with mCRPCs harboring HRR gene alterations, in particular
Identifiants
pubmed: 35330059
pii: jcm11061734
doi: 10.3390/jcm11061734
pmc: PMC8952857
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
N Engl J Med. 2020 Dec 10;383(24):2345-2357
pubmed: 32955174
J Hematol Oncol. 2021 Mar 29;14(1):51
pubmed: 33781305
J Clin Oncol. 2019 Feb 20;37(6):490-503
pubmed: 30625039
Ann Oncol. 2020 Sep;31(9):1119-1134
pubmed: 32593798
Lancet Oncol. 2022 Mar;23(3):362-373
pubmed: 35131040
Lancet Oncol. 2018 Jul;19(7):975-986
pubmed: 29880291
Clin Cancer Res. 2020 Jun 1;26(11):2487-2496
pubmed: 32086346
N Engl J Med. 2017 Aug 10;377(6):523-533
pubmed: 28578601
BMC Genomics. 2005 Oct 04;6:139
pubmed: 16202152
N Engl J Med. 2016 Aug 4;375(5):443-53
pubmed: 27433846
Prostate. 2014 Feb;74(2):210-6
pubmed: 24132735
Cell. 2015 May 21;161(5):1215-1228
pubmed: 26000489
Am J Kidney Dis. 2020 Dec;76(6):898-900
pubmed: 32679152
J Clin Oncol. 2013 May 10;31(14):1748-57
pubmed: 23569316
Cancers (Basel). 2021 Nov 20;13(22):
pubmed: 34830984
Xenobiotica. 2017 Oct;47(10):903-915
pubmed: 27684210
Nat Commun. 2017 Aug 29;8(1):374
pubmed: 28851861
Eur Urol. 2017 May;71(5):740-747
pubmed: 27989354
J Clin Oncol. 2020 Feb 10;38(5):395-405
pubmed: 31774688
Mol Cell Biol. 2004 Jan;24(2):708-18
pubmed: 14701743
Lancet Oncol. 2015 Jan;16(1):87-97
pubmed: 25481791
Sci Signal. 2017 May 23;10(480):
pubmed: 28536297
JAMA Oncol. 2021 Jun 4;:
pubmed: 34086042
Mod Pathol. 2016 Dec;29(12):1460-1470
pubmed: 27562496
J Pathol Clin Res. 2021 Jul;7(4):311-325
pubmed: 33630412
J Cell Biol. 2012 Oct 15;199(2):235-49
pubmed: 23045548
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Clin Cancer Res. 2021 Jan 15;27(2):566-574
pubmed: 32988971
Biopreserv Biobank. 2013 Apr;11(2):101-6
pubmed: 24845430
Xenobiotica. 2020 Sep;50(9):1032-1042
pubmed: 32129697
Genes Dev. 2017 Feb 1;31(3):318-332
pubmed: 28242626
Ann Oncol. 2020 Nov;31(11):1491-1505
pubmed: 32853681
Nat Struct Mol Biol. 2010 Oct;17(10):1260-2
pubmed: 20729859
Lancet Haematol. 2021 Feb;8(2):e122-e134
pubmed: 33347814
Lancet Oncol. 2022 Mar;23(3):393-405
pubmed: 35157830
Mol Cancer Res. 2009 Jul;7(7):1110-8
pubmed: 19584259
JCO Precis Oncol. 2020;4:370-381
pubmed: 32462107
Cancer Discov. 2013 Nov;3(11):1245-53
pubmed: 24027196
Nat Genet. 2018 May;50(5):682-692
pubmed: 29662167
Clin Cancer Res. 2011 Feb 1;17(3):401-5
pubmed: 21088254
N Engl J Med. 2019 Jul 25;381(4):317-327
pubmed: 31157963
J Clin Oncol. 2020 Aug 20;38(24):2798-2811
pubmed: 32516092
J Clin Oncol. 2017 Jan;35(1):40-47
pubmed: 28034081
Mol Cell Biol. 2003 Jun;23(11):3974-81
pubmed: 12748298
JAMA Oncol. 2021 Jan 1;7(1):107-110
pubmed: 33151258
Lancet Oncol. 2014 Jun;15(7):700-12
pubmed: 24831977
N Engl J Med. 2018 Dec 27;379(26):2495-2505
pubmed: 30345884
Lancet Oncol. 2020 Jan;21(1):162-174
pubmed: 31806540
J Natl Cancer Inst. 1999 Aug 4;91(15):1310-6
pubmed: 10433620
J Clin Invest. 2020 Apr 1;130(4):1743-1751
pubmed: 31874108
Prostate. 2018 Jun;78(8):607-615
pubmed: 29520813
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28825054
Nat Commun. 2020 Jul 24;11(1):3726
pubmed: 32709856
N Engl J Med. 2010 Jul 29;363(5):411-22
pubmed: 20818862
Cancer Discov. 2012 Dec;2(12):1134-49
pubmed: 22993403
Hum Mol Genet. 2001 Oct 1;10(20):2253-9
pubmed: 11673408
N Engl J Med. 2020 May 28;382(22):2091-2102
pubmed: 32343890
N Engl J Med. 2015 Oct 29;373(18):1697-708
pubmed: 26510020
J Pharmacol Exp Ther. 2014 Jun;349(3):408-16
pubmed: 24650937
J Clin Invest. 2019 Mar 1;129(3):1211-1228
pubmed: 30589644
Clin Cancer Res. 2022 Jan 28;:
pubmed: 35091440
J Clin Oncol. 2020 Nov 10;38(32):3763-3772
pubmed: 32795228
Eur Urol. 2019 Apr;75(4):667-675
pubmed: 30638634